Deputy Director of CSI Singapore, Prof. Goh Boon Cher has been awarded the NMRC Singapore Translational Research (STaR) Investigator Award for a groundbreaking project:

🧬“Advancing Immunotherapy for Nasopharyngeal Carcinoma through VEGF/PD1 Blockade: Mechanisms, Biomarkers, and Clinical Translation”.

Prof. Goh Boon Cher is a clinician scientist who specialises in cancer pharmacology and functional genomics. By coupling innovative biomarker discovery pipeline with the appropriate research validation tools, he leads a team of clinicians and scientists to identify early cancer markers and actionable mutations that could be implemented in biomarker-driven clinical trials. The overarching goal is to improve the cancer-screening process and provide better treatment options to cancer patients.